NeuroMetrix shares lose 9.1% after the company reports another quarter in the red.

NeuroMetrix (NSDQ:NURO) reported another consecutive quarter at a net loss, spurring a 9.1% drop on Wall Street yesterday, where shares closed at 50¢.

The Waltham, Mass.-based medical device maker reported net losses of $2.6 million, or 21¢ per share on sales of $1.8 million, in line with analysts expectations. That compared with a net loss of $2.4 million, or 63¢ per share, on sales of $2.6 million during the same period last year.